My Profile Shopping Cart Register Login
Logo and Name
 
CME/CE Programs About Us Why Register? Advisory Panel Links Contact Home
 
 

CME PROGRAM: Evaluating & Treating Newly Diagnosed Malignant Gliomas
PART I: EVALUATION & INITIAL PRESENTATION Patients who present with a possible malignant glioma ...
MORE

CME PROGRAM: Molecular Markers in GBM
There has been much excitement in neuro-oncology about molecular markers such as methylguanine methy...
MORE

CME PROGRAM: Treating Elderly Patients With the New Standard of Care
Age is a major prognostic factor in patients with malignant gliomas1.  Patients older than 50 h...
MORE

CME PROGRAM: MGMT Methylation and Its Role in GBM
Combining temozolomide (TMZ, Temodar®), an oral cytotoxic agent with concomitant radiation thera...
MORE

CME PROGRAM: Long-Term Survival in GBM: Is It Possible?
For patients with newly diagnosed glioblastoma (GBM), conversations about prognosis are becoming inc...
MORE

More Topics
Ask a Question

CME PROGRAM: Learning Through Q&A: Responses From Neuro-Oncology Experts to Diagnostic and Treatment Queries - Questions From 2008
What were the questions that were asked and responded to in 2008?  Learning Through Q&A: Re...
MORE

More Ask the Experts Questions & Responses

 

Disclaimer
The content of this web site is designed to serve the educational needs of physicians and other licensed healthcare professionals. It is not intended for the educational needs of patients and will not respond to patient inquiries. Any medications, diagnostic procedures, or treatments discussed by web site contributors should not be used by clinicians or other healthcare professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.

 
 
  your resource for FREE* professional education publications, videos, multimedia, and online activities designed for healthcare professionals interested in the treatment of primary and metastatic brain cancer. Programs are added frequently and cover topics including: radiotherapy and radiosurgery for malignant glioma; combination chemotherapy and biological agents; molecular markers, and more. Please visit this site often to find new programs that may interest you and your colleagues.
   
 
 
Changes to this website
GliomaEd has undergone some recent changes to make the content more useful to you and your practice. Each program, including the brief Current Topics ...

MORE

ISPNO
14th International Smposium on Pediatric Neuro-Oncology
June 20-23, 2010
Vienna, Austria...

MORE

34th ESMO Congress
European Society of Medical Oncology
September 20-24, 2009
Berlin, Germany...

MORE

The European Cancer Conference
ECCO 15
September 20-24, 2009
Berlin, Germany...

MORE

CNS
2009 Congress of Neurological Surgeons
October 24-29, 2009
New Orleans, LA...

MORE

More Announcements

 

     

This online community is sponsored by AKH Inc, Advancing Knowledge and Healthcare,

facilitated by Medical Communications Media,

and commercially supported by an educational grant from Schering-Plough

View Our Privacy Policy

*All programs are shipped to your home or office, or are available for online viewing at absolutely no cost to you. For most programs the CME/CE processing is free as well. However, a few credit providers require a nominal certificate or statement of credit fee due upon submission of the post-test. If this is the case for the program in which you are interested, it will be clearly stated in the program description.

This site is best viewed with Java, Javascript, and Cookies enabled, and is optimized for a resolution of 800x600 and Microsoft Internet Explorer v. 5.0 or higher or Netscape Navigator v. 6.2 or higher. Please click on the icon below to update your browser.

Copyright © 2009, Medical Communications Media, Inc. All rights reserved.